ATRX and soft tissue sarcoma: A genetic analysis of a large cohort of 2138 sarcomas spanning over 45 sarcoma subtypes identified >10% loss of ATRX expression across various soft tissue sarcoma subtypes, with uLMS having the highest mutation rate of up to one in three cases [20].